glp-1 heart attack New Mechanisms to Prevent Failure with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic Syndrome and in Type 2 Diabetes: A Review Frontiers | GLP-1 Receptor Agonists

Limited human data exists about GLP-1 medications transferring into breast milk, making safety during breastfeeding unclear

Injectable GHK-Cu was in Category 2 the more restrictive category for substances with "significant safety concerns." Its removal from Category 2 is the more positive development, as it signals the FDA no longer considers injectable GHK-Cu to carry the safety risk level that warranted Category 2 placement

Thyroid 27(5):746747 Morgan SJ, Neumann S, Marcus-Samuels B et al (2016) Thyrotropin and insulin-like growth factor 1 receptor crosstalk upregulates sodium-iodide symporter expression in primary cultures of human thyrocytes

Because it is directly administered into the bloodstream, it significantly enhances its potency and absorption rate compared to oral supplements